MedPath

Yoga in advanced adult cancer patients in a Respite Palliative Care setting in India

Recruiting
Conditions
Neoplasms,
Registration Number
CTRI/2021/11/037871
Lead Sponsor
Tata Memorial Hospital
Brief Summary

This study aims to evaluate the feasibility and effectiveness of yoga interventions in reducing symptoms, change in anxiety, depression, change in spiritual wellbeing.There is a need to create mindfulness in the population as well as healthcare professionals about the benefits of yoga in symptom management and dealing with psychological and spiritual needs; this study aims to address this.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
100
Inclusion Criteria

1 Age 18 and above 2 ECOG 0-3 3 Patient admitted at Respite care facility for minimum of 7 days 4 Having ability to comprehend English / Hindi / Marathi 5 Able to provide written informed consent.

Exclusion Criteria

1 Any evaluable Cognitive impairment 2 Already practicing any form of yoga on regular basis 3 Unable to perform/ adhere yoga intervention 4 Any deterioration in physical condition.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of adult advanced cancer patients able to attend yoga sessions for 7 daysNumber of adult advanced cancer patients able to attend yoga sessions for 7 days
Secondary Outcome Measures
NameTimeMethod
Change in presence of depression and anxiety from baseline to 7 days as measured by PHQ-9 and GAD-7Change in symptom burden from baseline to 7 days in patients, as measured by ESAS
Compliance after dischargeWe will check for compliance at 15 days and one month.

Trial Locations

Locations (1)

Respite Palliative Care Unit, Dr. Ernest Borges Memorial Home

🇮🇳

Mumbai, MAHARASHTRA, India

Respite Palliative Care Unit, Dr. Ernest Borges Memorial Home
🇮🇳Mumbai, MAHARASHTRA, India
DrJayita Deodhar
Principal investigator
7045390210
jukd2000@yahoo.co.uk

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.